关注
Salvador Castaneda-Vega
Salvador Castaneda-Vega
在 med.uni-tuebingen.de 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Generation of a novel rodent model for DYT1 dystonia
K Grundmann, N Glöckle, G Martella, G Sciamanna, TK Hauser, L Yu, ...
Neurobiology of disease 47 (1), 61-74, 2012
872012
In vivo molecular profiling of human glioma using diffusion kurtosis imaging
JM Hempel, S Bisdas, J Schittenhelm, C Brendle, B Bender, H Wassmann, ...
Journal of neuro-oncology 131, 93-101, 2017
842017
Endothelial depletion of murine SRF/MRTF provokes intracerebral hemorrhagic stroke
C Weinl, S Castaneda Vega, H Riehle, C Stritt, C Calaminus, H Wolburg, ...
Proceedings of the National Academy of Sciences 112 (32), 9914-9919, 2015
572015
In vivo assessment of tumor heterogeneity in WHO 2016 glioma grades using diffusion kurtosis imaging: Diagnostic performance and improvement of feasibility in routine clinical …
JM Hempel, J Schittenhelm, S Bisdas, C Brendle, B Bender, G Bier, ...
Journal of Neuroradiology 45 (1), 32-40, 2018
452018
Quantitative rodent brain receptor imaging
K Herfert, JG Mannheim, L Kuebler, S Marciano, M Amend, C Parl, ...
Molecular Imaging and Biology 22, 223-244, 2020
362020
Histogram analysis of diffusion kurtosis imaging estimates for in vivo assessment of 2016 WHO glioma grades: A cross-sectional observational study
JM Hempel, J Schittenhelm, C Brendle, B Bender, G Bier, M Skardelly, ...
European journal of radiology 95, 202-211, 2017
362017
Impact of 18F-FET PET/MRI on clinical management of brain tumor patients
C Brendle, C Maier, B Bender, J Schittenhelm, F Paulsen, M Renovanz, ...
Journal of Nuclear Medicine 63 (4), 522-527, 2022
272022
In vivo molecular profiling of human glioma: cross-sectional observational study using dynamic susceptibility contrast magnetic resonance perfusion imaging
JM Hempel, J Schittenhelm, U Klose, B Bender, G Bier, M Skardelly, ...
Clinical Neuroradiology 29, 479-491, 2019
262019
ADC-based stratification of molecular glioma subtypes using high b-value diffusion-weighted imaging
NC Nuessle, F Behling, G Tabatabai, S Castaneda Vega, J Schittenhelm, ...
Journal of Clinical Medicine 10 (16), 3451, 2021
172021
Characterization of a novel murine model for spontaneous hemorrhagic stroke using in vivo PET and MR multiparametric imaging
SC Vega, C Weinl, C Calaminus, L Wang, M Harant, W Ehrlichmann, ...
Neuroimage 155, 245-256, 2017
172017
Effect of perfusion on diffusion kurtosis imaging estimates for in vivo assessment of integrated 2016 WHO glioma grades: a cross-sectional observational study
JM Hempel, J Schittenhelm, C Brendle, B Bender, G Bier, M Skardelly, ...
Clinical Neuroradiology 28, 481-491, 2018
162018
Machine learning identifies stroke features between species
S Castaneda-Vega, P Katiyar, F Russo, K Patzwaldt, L Schnabel, ...
Theranostics 11 (6), 3017, 2021
142021
Differences in the expression of SSTR1–5 in meningiomas and its therapeutic potential
F Behling, C Fodi, M Skardelly, M Renovanz, S Castaneda, G Tabatabai, ...
Neurosurgical Review, 1-12, 2022
132022
Image Quality and Quantitative PET Parameters of Low-Dose [18F]FDG PET in a Long Axial Field-of-View PET/CT Scanner
E Calderón, FP Schmidt, W Lan, S Castaneda-Vega, AS Brendlin, ...
Diagnostics 13 (20), 3240, 2023
112023
The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma
C Fodi, M Skardelly, JM Hempel, E Hoffmann, S Castaneda, G Tabatabai, ...
Neurosurgical Review, 1-9, 2022
102022
Selective protection of murine cerebral Gi/o-proteins from inactivation by parenterally injected pertussis toxin
SC Vega, V Leiss, R Piekorz, C Calaminus, K Pexa, M Vuozzo, ...
Journal of Molecular Medicine 98, 97-110, 2020
102020
The current role of peptide receptor radionuclide therapy in meningiomas
CK Fodi, J Schittenhelm, J Honegger, SG Castaneda-Vega, F Behling
Journal of Clinical Medicine 11 (9), 2364, 2022
92022
Glioma-specific diffusion signature in diffusion kurtosis imaging
JM Hempel, C Brendle, SD Adib, F Behling, G Tabatabai, ...
Journal of Clinical Medicine 10 (11), 2325, 2021
82021
Multiparametric longitudinal profiling of RCAS-tva-Induced PDGFB-driven experimental glioma
H Becker, S Castaneda-Vega, K Patzwaldt, JM Przystal, B Walter, ...
Brain Sciences 12 (11), 1426, 2022
62022
Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke
K Patzwaldt, G Berezhnoy, T Ionescu, L Schramm, Y Wang, M Owczorz, ...
Brain Communications 5 (2), fcad099, 2023
52023
系统目前无法执行此操作,请稍后再试。
文章 1–20